Supporting innovation in Canada with genOway’s solutions
Canada has a strong and growing life sciences ecosystem, with scientific innovation spanning biotech, academia, hospitals, and translational research centres. As promising programs move from discovery toward development, one of the key challenges is generating preclinical evidence that is relevant, predictive, and capable of supporting the next critical decision.
genOway Canada was established to support Canadian teams at this stage of development by providing local access to genOway’s predictive preclinical models, scientific expertise, and broader capabilities.
Canadian researchers have access to two complementary solutions: validated catalog models that can be readily deployed, and custom model generation for programs requiring a model tailored to a specific target, pathway, or translational question. Clients can also access genOway’s broader preclinical capabilities and study design support.
genOway Canada also helps simplify access to models with certified health status maintained through professional breeding networks in US and Europe, with coordinated door-to-door delivery to teams across Canada.
